-
We represented Gintarinė vaistinė and Limedika in a major antitrust case—the largest in Lithuania’s history. These pharmaceutical companies were fined over EUR 25 million by the Lithuanian Competition Council (LCC) for allegedly coordinating with competitors while lobbying. The LCC claimed they submitted data to the Ministry of Health that influenced the Ministry’s decision to approve […]
-
As part of last year’s Shared Mission project, we provided pro bono legal assistance to MILDEC PRO, an innovative defence industry company. The aim was to structure MILDEC PRO for investment and public procurement. MILDEC PRO focuses on producing lightweight, convincing and easily deployable military decoys for high-value targets. The use of military decoys is […]
-
We advised EIKA Group on the acquisition of the shares in a company that owns a building complex located at Visorių St. 20 in Vilnius. The site is intended for the development of a residential project meeting A++ energy efficiency standards. The project will be implemented in several stages, with more than 500 apartments planned in […]
-
OC VISION, the largest vision care company in the Baltics, has successfully raised EUR 10 million through its first public bond offering with a fixed annual coupon rate of 6%. Total demand for the secured bonds reached EUR 13.1 million, oversubscribed by more than 130%. About the bond offering The offering attracted interest from both […]
-
In this newsletter, we discuss legal news which broadly impacts the life sciences and healthcare sector, as well as updates specifically relevant to research and development. This time we are covering: At the EU level, the Council is now ready to begin negotiations with the European Parliament about the “pharma package”, and a regulation is […]
